|
The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: Modelling study
|
Journal of Cancer Policy
|
2022
|
|
|
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study
|
Journal of Medical Screening
|
2022
|
|
|
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
|
The Lancet Gastroenterology and Hepatology
|
2021
|
|
|
Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials
|
Medical Decision Making
|
2020
|
|
|
Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia
|
BMJ Open
|
2020
|
|
|
Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment
|
PLOS One
|
2020
|
|
|
Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia
|
Public Health
|
2020
|
|
|
Benefits, harms and costs of potential age-extensions to the National Bowel Cancer Screening Program in Australia: Impact of inviting people aged 40-49 years and 75-84 years
|
Cancer Epidemiology, Biomarkers and Prevention
|
2018
|
|
|
Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia
|
International Journal of Cancer
|
2018
|
|
|
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
|
The Lancet Public Health
|
2017
|
|